- Home
- PLRX vs CTO Comparison
PLRX vs CTO Comparison
Compare PLRX & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | CTO |
|---|---|---|
| Founded | 2015 | 1902 |
| Country | United States | United States |
| Employees | 49 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.1M | 776.3M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PLRX | CTO |
|---|---|---|
| Price | $0.97 | $20.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $2.67 | ★ $24.60 |
| AVG Volume (30 Days) | 367.8K | ★ 378.0K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 7.33% |
| EPS Growth | 29.97 | ★ 122.86 |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $149,545,000.00 |
| Revenue This Year | N/A | $18.22 |
| Revenue Next Year | N/A | $9.81 |
| P/E Ratio | ★ N/A | $159.62 |
| Revenue Growth | N/A | ★ 20.10 |
| 52 Week Low | $0.97 | $15.59 |
| 52 Week High | $1.95 | $22.71 |
Technical Indicators
Market Signals| Indicator | PLRX | CTO |
|---|---|---|
| Relative Strength Index (RSI) | 32.34 | 49.98 |
| Support Level | N/A | $19.87 |
| Resistance Level | $1.37 | $20.86 |
| Average True Range (ATR) | 0.04 | 0.35 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 4.61 | 70.37 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties in diversified markets in the United States. The company operates in four primary business segments: Income properties, management services, commercial loans and investments, and real estate operations. It derives maximum revenue from Income Properties.